Inventor · disambiguated record
Martin Weisser
Also filed as: WEISSER MARTIN
3 granted patents·5 pending applications·15 citations·filing 2013–2024
62Inventor score
Files withHOFFMANN LA ROCHE8
Top patents by PatentIndex Score
8 records- 0188US9180185B2Combination therapy of anti-HER3 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Nov 10, 2015·13 cites·15 claims
- 0269US11498968B2Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatmentHOFFMANN LA ROCHE·Filed 2019·Granted Nov 15, 2022·2 cites·12 claims
- 0361US2025206835A1Dosing for combination treatment with anti-cd20/anti-cd3 bispecific antibody and anti-cd79b antibody drug conjugateHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0456US12195547B2Dosing for combination treatment with anti-CD20/anti-CD3 bispecific antibody and anti-CD79B antibody drug conjugateHOFFMANN LA ROCHE·Filed 2022·Granted Jan 14, 2025·0 cites·28 claims
- 0555US2024352136A1Antibodies for the treatment of amlHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0647US2022372156A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0741US2016159912A1Combination therapy of anti-her3 antibodiesHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 0836US2014017230A1Chronic lymphocytic leukemia (cll) biomarkersHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →